Literature DB >> 26702504

Polyphenols from Cymbopogon citratus leaves as topical anti-inflammatory agents.

Gustavo Costa1, João Pinto Ferreira2, Carla Vitorino2, Maria Eugénia Pina3, João José Sousa2, Isabel Vitória Figueiredo4, Maria Teresa Batista2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: A variety of plant polyphenols have been reported to have anti-inflammatory, frequently associated with erythema, edema, hyperplasia, skin photoaging and photocarcinogenesis. Cymbopogon citratus (DC). Stapf (Poaceae) is a worldwide known medicinal plant, used in traditional medicine in inflammation-related conditions. AIM OF THE STUDY: In this work, the anti-inflammatory potential of C. citratus infusion (CcI) and its polyphenols as topical agents was evaluated in vivo.
MATERIALS AND METHODS: The plant extract was prepared and its fractioning led two polyphenol-rich fractions: flavonoids fraction (CcF) and tannins fraction (CcT). An oil/water emulsion was developed with each active (CcI, CcF+CcT and diclofenac), pH and texture having been evaluated. Release tests were further performed using static Franz diffusion cells and all collected samples were monitored by HPLC-PDA. In vivo topical anti-inflammatory activity evaluation was performed by the carrageenan-induced rat paw edema model.
RESULTS: The texture analysis revealed statistically significant differences for all tested parameters to CcF+CcT, supporting its topical application. Release experiments lead to the detection of the phenolic compounds from each sample in the receptor medium and the six major flavonoids were quantified, by HPLC-PDA: carlinoside, isoorientin, cynaroside, luteolin 7-O-neohesperidoside, kurilesin A and cassiaoccidentalin B. The CcF+CcT formulation prompted to the higher release rate for all these flavonoids. CcI4%, CcI1% and CcF+CcT exhibited an edema reduction of 43.18, 29.55 and 59.09%, respectively.
CONCLUSIONS: Our findings highlight that CcI, containing luteolin 7-O-neohesperidoside, cassiaoccidentalin B, carlinoside, cynaroside and tannins have a potential anti-inflammatory topical activity, suggesting their promising application in the treatment of skin inflammatory pathologies.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Cymbopogon citratus; Drug release; Lemongrass; Topical application; in vivo studies

Mesh:

Substances:

Year:  2015        PMID: 26702504     DOI: 10.1016/j.jep.2015.12.016

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Antioxidant and anti-inflammatory effects of polyphenols extracted from Ilex latifolia Thunb.

Authors:  Tian-Tian Zhang; Ting Hu; Jian-Guo Jiang; Jing-Wen Zhao; Wei Zhu
Journal:  RSC Adv       Date:  2018-02-14       Impact factor: 4.036

2.  Lemongrass (Cymbopogon citratus) oil: A promising miticidal and ovicidal agent against Sarcoptes scabiei.

Authors:  Meilin Li; Buming Liu; Charlotte Bernigaud; Katja Fischer; Jacques Guillot; Fang Fang
Journal:  PLoS Negl Trop Dis       Date:  2020-04-06

3.  Crepis vesicaria L. subsp. taraxacifolia Leaves: Nutritional Profile, Phenolic Composition and Biological Properties.

Authors:  Sónia Pedreiro; Sandrine da Ressurreição; Maria Lopes; Maria Teresa Cruz; Teresa Batista; Artur Figueirinha; Fernando Ramos
Journal:  Int J Environ Res Public Health       Date:  2020-12-28       Impact factor: 3.390

Review 4.  Review of phytomedicine, phytochemistry, ethnopharmacology, toxicology, and pharmacological activities of Cymbopogon genus.

Authors:  Jonnea Japhet Tibenda; Qiong Yi; Xiaobo Wang; Qipeng Zhao
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

5.  Bio-efficacy of medicinal plants used for the management of diabetes mellitus in Gabon: An ethnopharmacological approach.

Authors:  Olga Pauline Tjeck; Alain Souza; Patrick Mickala; Alexis Nicaise Lepengue; Bertrand M'Batchi
Journal:  J Intercult Ethnopharmacol       Date:  2017-04-17

6.  Bioactivities of Traditional Medicinal Plants in Alexandria.

Authors:  Hosam O Elansary; Agnieszka Szopa; Paweł Kubica; Halina Ekiert; Hayssam M Ali; Mohamed S Elshikh; Eslam M Abdel-Salam; Mohamed El-Esawi; Diaa O El-Ansary
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-31       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.